| 7JU6: reference: Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations., Subbiah V, Shen T, Terzyan SS, Liu X, Hu X, Patel KP, Hu M, Cabanillas M, Behrang A, Meric-Bernstam F, Vo PTT, Mooers BHM, Wu J, Ann Oncol. 2020 Nov 5. pii: S0923-7534(20)43127-8. doi:, 10.1016/j.annonc.2020.10.599. PMID: 33161056 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).